⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NSPR News
InspireMD, Inc.
InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Procedures
globenewswire.com
NSPR
InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures
globenewswire.com
NSPR
Form 8-K
sec.gov
NSPR
Form 8-K
sec.gov
NSPR
InspireMD to Participate in Upcoming Bank of America Securities 2026 Global Healthcare Conference
globenewswire.com
NSPR
Form 8-K
sec.gov
NSPR
InspireMD Reports First Quarter 2026 Financial Results
globenewswire.com
NSPR
Form 8-K
sec.gov
NSPR
InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System
globenewswire.com
NSPR
InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery System
globenewswire.com
NSPR